Advertisement

Search Results for "Neurovision One Session Trial"

21:32 EDT 25th May 2013 | BioPortfolio

Original Source: Evaluating NeuroVision's Neural Vision Correction (NVC) Myopia Treatment

The purpose of the present study is to carry out a trial to evaluate the clinical efficacy of the NeuroVision Low Myopia Treatment. The specific questions to be answered are: 1. Is there an improvement in vision following the treatment without bringing about a change in the subject's prescription for glasses? 2. Can any treatment effect be seen at 6 months and 12 months after the termination of the treatment?

Matching Channels

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...

Clinical Approvals - news, views, reports and blogs

Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and eff...

Xofigo (radium-223 dichloride)

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...

Vitamin E Toxicity

Research has not found any adverse effects from consuming vitamin E in food. However, high doses of alpha-tocopherol supplements can cause hemorrhage and interrupt blood coagulation in animals, and...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Matching News

Gilead’s Ranexa Reduces Angina Frequency in Study of Chronic Angina Patients With Type 2 Diabetes

Data Presented at Late-Breaking Clinical Trial Session at the American College of Cardiology’s Annual Scientific Session

Court reverses ruling against NuVasive in trademark suit

Sept 11 (Reuters) - Medical device maker NuVasive Inc said a U.S. circuit court reversed a verdict by a district court that required the company to pay $60 million in a trademark suit concerning its...

Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial

Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US non-profit organisation, the Foundation Fighting Blindness (FFB), has granted an award of US$125,000...

Frustrating Trading Session For Sarepta

By Brian L. Wilson:It was a frustrating trading session for anyone who has been faithful to Sarepta Therapeutics (SRPT) after the company released solid Phase II trial data for its flagship drug etipl...

Gilead's Ranexa Reduces Angina Frequency in Study of Chronic Angina Patients With Type 2 Diabetes

- Data Presented at Late-Breaking Clinical Trial Session at the American College of Cardiology's Annual Scientific Session - SAN FRANCISCO--(BUSINESS WIRE)--Mar 10, 2013 - Gilead Sciences, Inc. (Nasda...

Doctors React to ACC PREVAIL Cancellation

Many cardiologists expressed disappointment that they did not get to hear the PREVAIL results at the ACC late-breaking trial session this morning. But the ACC is standing by its decision to pull the p...

New trial results support treatment with Inspra (eplerenone) within first 24 hours of symptoms, in addition to standard therapy, in patients with acute STEMI without heart failure.

Pfizer Inc. (NYSE: PFE) today announced results from the REMINDER trial showing statistically significant risk reductions in the primary composite efficacy endpoint. The composite...

DKCRUSH-III trial results show differences in technically challenging bifurcation lesions

Patients with a type of coronary lesion linked with poor prognosis fared significantly better with the stent technique known as double kissing crush than with culotte stenting, according to data from...

Matching PubMed Articles

Effects of caffeine on session ratings of perceived exertion.

This study examined effects of caffeine on session ratings of perceived exertion (RPE) following 30 min constant-load cycling. Individuals (n = 15) of varying aerobic fitness completed a [Formula:...

Session perceived exertion and affective responses to self-selected and imposed cycle exercise of the same intensity in young men.

Session perceived exertion (S-RPE) and session affective responses (S-AR) are post-exercise estimates of the global responses experienced during exercise. To compare S-RPE and S-AR to acute RPE (A-RPE...

Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials.

INTRODUCTION: Although hyperbaric oxygen therapy (HBO) is broadly used for carbon monoxide (CO) poisoning, its efficacy and practical modalities remain controversial. OBJECTIVES: To assess HBO in pati...

Midsession reversal learning: why do pigeons anticipate and perseverate?

Past research has shown that when given a simultaneous visual-discrimination midsession reversal task, pigeons typically anticipate the reversal well before it occurs and perseverate after it occurs....

A pragmatic randomized controlled trial of a guided self-help intervention versus a waiting list control in a routine primary care mental health service.

Objectives To evaluate the effectiveness of a two session guided self-help (GSH) intervention provided by primary care graduate mental health workers (PCGMHWs) in a primary care mental health service....

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement